SRDX Logo

Surmodics, Inc. (SRDX) 

NASDAQ
Market Cap
$549.14M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
727 of 776
Rank in Industry
94 of 100

Largest Insider Buys in Sector

SRDX Stock Price History Chart

SRDX Stock Performance

About Surmodics, Inc.

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to …

Insider Activity of Surmodics, Inc.

Over the last 12 months, insiders at Surmodics, Inc. have bought $0 and sold $0 worth of Surmodics, Inc. stock.

On average, over the past 5 years, insiders at Surmodics, Inc. have bought $0 and sold $1.43M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,500 shares for transaction amount of $30,536 was made by KNIGHT SUSAN E (director) on 2014‑05‑08.

List of Insider Buy and Sell Transactions, Surmodics, Inc.

2022-11-28Saledirector
4,366
0.0314%
$34.89$152,321-13.40%
2022-11-14Saledirector
2,773
0.0191%
$33.00$91,507-12.13%
2022-11-11Saledirector
2,733
0.0195%
$33.48$91,511-10.24%
2022-04-01SalePresident & CEO
100
0.0007%
$45.55$4,555-22.80%
2022-02-28Saledirector
4,366
0.0314%
$44.97$196,332-20.68%
2022-01-04SaleSVP, HR and GM, IVD
2,500
0.0186%
$50.00$125,000-24.02%
2021-11-30Saledirector
5,576
0.0402%
$44.00$245,350-13.64%
2021-11-24Saledirector
3,475
0.0246%
$47.01$163,360-20.31%
2021-11-01SalePresident & CEO
6,000
0.0434%
$54.65$327,904-27.75%
2021-10-01SalePresident & CEO
6,000
0.0428%
$56.02$336,097-25.26%
2021-09-15SalePresident & CEO
6,000
0.0431%
$57.23$343,359-25.74%
2021-08-31SaleSenior VP of Bus Dev, Med Dev
1,292
0.0093%
$59.75$77,197-28.08%
2021-08-19SaleSVP, HR and GM, IVD
2,500
0.0179%
$54.40$136,002-20.79%
2021-08-11SaleCorporate Controller
2,608
0.0187%
$53.35$139,136-18.53%
2021-05-20SaleSVP, HR and GM, IVD
2,500
0.0181%
$53.80$134,506-9.08%
2021-04-28SaleSenior VP of Bus Dev, Med Dev
1,508
0.011%
$59.75$90,103-10.93%
2021-04-16SaleSenior VP of Bus Dev, Med Dev
648
0.0048%
$59.75$38,718-8.87%
2021-03-31SaleSenior VP of Bus Dev, Med Dev
4,759
0.0348%
$56.75$270,073-4.74%
2021-03-01SalePresident & CEO
4,000
0.0286%
$52.06$208,259+1.58%
2021-02-26Saledirector
5,576
0.0407%
$52.36$291,955+3.35%

Insider Historical Profitability

8.91%
DANTZKER DAVIDdirector
34178
0.2396%
$38.4913<0.0001%
KNIGHT SUSAN Edirector
30196
0.2116%
$38.4926+11.09%
BUHRMASTER ROBERT Cdirector
2625
0.0184%
$38.4910+18.46%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Trigran Investments, Inc.$69.19M16.542.36M0%+$06.71
BlackRock$30.86M7.381.05M-2.62%-$831,114.19<0.01
The Vanguard Group$25.39M6.07865,214+0.69%+$173,898.17<0.0001
Morgan Stanley$25.05M5.99853,915-31.23%-$11.38M<0.01
Soleus Capital Management, L.P.$23.5M5.62800,820+3.77%+$854,380.810.1
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.